How to use the speech recognition tool?
An Open-Label Safety Study of Retinal Gene Therapy for Choroideremia with Bilateral,
Sequential Administration of Adeno-Associated Viral Vector (AAV2) Encoding Rab Escort Protein 1 (REP1).
Status of the trial: Active, Not recruiting
Orphan Drug Recognition: Yes
Funder Type: industry
Principal location of the trial
HCP: Principal investigators
HCP: Other investigators